Engage: A Telehealth Program to Help Patients with Advanced Cancer Manage Symptoms
Engage: A Randomized Controlled Trial Testing the Efficacy of a Telehealth-Delivered Psychosocial Intervention to Decrease Symptom Interference in Patients with Advanced Cancer
This program offers a telehealth-delivered approach to help patients with advanced cancer better manage symptoms like pain, fatigue, and distress that interfere with their daily lives.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-11158704 on NIH RePORTER |
What this research studies
Patients living with advanced cancer often experience challenging symptoms such as pain, tiredness, and emotional distress, which can make it hard to live life fully. Current medical treatments for these symptoms sometimes have side effects or don't fully address all concerns. This program, called ENGAGE, combines traditional coping skills with acceptance and mindfulness techniques to help you reduce symptom severity and accept experiences that cannot be changed. The goal is to lessen how much these symptoms disrupt your life and improve your overall well-being. This approach is delivered remotely, making it accessible from your home.
Who could benefit from this research
Good fit: Ideal candidates are patients with advanced cancer who are experiencing significant pain, fatigue, or distress that interferes with their daily activities.
Not a fit: Patients who do not have advanced cancer or are not experiencing significant symptom interference may not find this program beneficial.
Why it matters
Potential benefit: If successful, this program could offer patients with advanced cancer a new way to reduce the impact of difficult symptoms on their daily lives and significantly improve their quality of life.
How similar studies have performed: Pilot programs using this approach have shown promising results, but this larger effort aims to confirm its effectiveness in a more comprehensive way.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Winger, Joseph Giles — Duke University
- Study coordinator: Winger, Joseph Giles
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.